Through the integrated network pharmacology pan-cancer analysis of the effective components of T. hemsleyanum, this study has shown that T. hemsleyanum acts as a cell cycle checkpoint inhibitor and a tyrosine kinase receptor inhibitor and has demonstrated the multi-target nature of T. hemsleyanum as a natural product, which was verified by bioinformatics analysis combined with experiments. Here, NTRK1 is linked to cancer.